What caused IHL.AX stock to move sharply today?

Shares moved after Incannex added three senior members to its Clinical Advisory Board on 29 Jan 2026. Heavy intraday volume of 61,360,016 amplified the reaction, pushing the price to A$0.041, a -10.87% decline on the ASX.

What is Meyka AI’s view on IHL.AX stock?

Meyka AI rates IHL.AX **61.04 (B)** with a HOLD suggestion. The model projects a 12‑month price of A$0.070 versus the current A$0.041. Forecasts are model outputs and not investment advice.

What are the key financials to watch for IHL.AX stock?

Monitor EPS (currently -1.30), cash per share A$0.02171, R&D spend and cash runway. Also watch average price lines: 50‑day A$0.0649 and 200‑day A$0.10285, plus any capital‑raise announcements.

How should traders manage IHL.AX stock volatility?

Given the stock’s high intraday volume and speculative profile, use strict position sizing, stop losses, and monitor clinical news flow and funding updates closely. Liquidity spikes can widen spreads rapidly.

AU Stocks

IHL.AX Incannex Healthcare ASX down 10.87% intraday 30 Jan 2026: CAB adds depth

ByHuzaifa Zahoor January 30, 2026January 30, 2026

IHL.AX stock led ASX intraday activity on 30 Jan 2026 after shares fell to A$0.041, down -10.87% on heavy volume. Trading volume hit 61,360,016 versus an average of 6,427,691, marking it as one of the most active names on the Australian exchange. The move follows Incannex Healthcare Limited’s appointment of three senior clinicians to its Clinical Advisory Board, a near-term catalyst for the PSX-001 program. Key metrics: market cap A$14,255,927, EPS -1.30, and PE (TTM) -3.15. Meyka AI’s platform flags the stock for high liquidity and event-driven volatility.